This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Thursday's Health Winners & Losers

Shares of Matria Healthcare (MATR) were among the worst-performing health-related stocks Thursday, plunging 19% after the health-services company slashed its 2006 earnings and revenue outlook.

The company now sees full-year earnings from continuing operations of $1.10 to $1.17 a share, down from an earlier prediction of $1.35 to $1.50 a share. The guidance excludes stock-based compensation costs of 25 cents to 30 cents a share. The company now sees revenue of $337 million to $341 million, down from an earlier view of $360 million to $370 million. Analysts polled by Thomson First Call project earnings of $1.10 a share, including stock-based compensation costs, and revenue of $360.7 million.

"The market's reaction to our acquisition of CorSolutions appears to be a general delay in awarding new employer business to Matria," the company said. "Because our acquisition of CorSolutions is currently the largest transaction of this nature to occur in the disease management market, consultants and prospective clients are being cautious."

Matria continues to see second-quarter earnings from continuing operations of 23 cents to 26 cents a share, with revenue of $82 million to $84 million. Analysts project earnings of 19 cents a share, including 7 cents in compensation costs, on revenue of $84 million. Shares were trading down $5.20 to $22.16.

Advanced Medical Optics (EYE) rose 2% after the eye-care products company raised its 2006 earnings guidance and backed its revenue forecast. The company now sees earnings of $2.03 to $2.19 a share, up from an earlier view of $2 to $2.15 a share. Analysts project earnings of $2.03 a share. Advanced Medical said the new outlook reflects its stock buyback, a note offering and the purchase of outstanding debt. The company continues to see revenue of $1.02 billion to $1.04 billion, bracketing analysts' mean estimate of $1.03 billion.

For 2007, the company now sees earnings of at least $2.60 a share, up from a previous forecast that called for earnings of at least $2.45 a share. The company predicts revenue of $1.1 billion to $1.12 billion. Analysts project 2007 earnings of $2.50 a share on revenue of $1.1 billion. Shares were trading up 74 cents to $46.59.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,906.42 +101.62 0.57%
S&P 500 2,073.62 +2.97 0.14%
NASDAQ 4,773.5410 +8.1610 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs